It was observed that SARS-CoV-2 infection exhibited a high degree of heterogeneity within all the three arms of the adaptive immune response, including memory B cells, CD8+ T cells and CD4+ T cells amongst more than 90% of COVID-19 patients [123]. The gene discussed is CD4; the disease is COVID-19.